TY - JOUR
T1 - Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain
AU - LANCOVID
AU - Escalera-Antezana, Juan Pablo
AU - Lizon-Ferrufino, Nicolas Freddy
AU - Maldonado-Alanoca, Americo
AU - Alarcón-De-la-Vega, Gricel
AU - Alvarado-Arnez, Lucia Elena
AU - Balderrama-Saavedra, María Alejandra
AU - Bonilla-Aldana, D. Katterine
AU - Rodríguez-Morales, Alfonso J.
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Introduction: In March 2020, Coronavirus Disease 2019 (COVID-19) arrived in Bolivia. Here, we report the main clinical findings, and epidemiological features of the first series of cases, and a cluster, confirmed in Bolivia. Methods: For this observational, retrospective and cross-sectional study, information was obtained from the Hospitals and the Ministry of Health for the cases that were laboratory-diagnosed and related, during March 2020. rRT-PCR was used for the detection of the RNA of SARS-CoV-2 following the protocol Charité, Berlin, Germany, from nasopharyngeal swabs. Results: Among 152 suspected cases investigated, 12 (7.9%) were confirmed with SARS-CoV-2 infected by rRT-PCR. The median age was 39 years (IQR 25–43), six of them male. Two cases proceed from Italy and three from Spain. Nine patients presented fever, and cough, five sore throat, and myalgia, among other symptoms. Only a 60 y-old woman with hypertension was hospitalized. None of the patients required ICU nor fatalities occurred in this group. Conclusions: This is the first report of surveillance of COVID-19 in Bolivia, with patients managed mainly with home isolation. Preparedness for a significant epidemic, as is going on in other countries, and the deployment of response plans for it, in the country is now taking place to mitigate the impact of the COVID-19 pandemic in the population.
AB - Introduction: In March 2020, Coronavirus Disease 2019 (COVID-19) arrived in Bolivia. Here, we report the main clinical findings, and epidemiological features of the first series of cases, and a cluster, confirmed in Bolivia. Methods: For this observational, retrospective and cross-sectional study, information was obtained from the Hospitals and the Ministry of Health for the cases that were laboratory-diagnosed and related, during March 2020. rRT-PCR was used for the detection of the RNA of SARS-CoV-2 following the protocol Charité, Berlin, Germany, from nasopharyngeal swabs. Results: Among 152 suspected cases investigated, 12 (7.9%) were confirmed with SARS-CoV-2 infected by rRT-PCR. The median age was 39 years (IQR 25–43), six of them male. Two cases proceed from Italy and three from Spain. Nine patients presented fever, and cough, five sore throat, and myalgia, among other symptoms. Only a 60 y-old woman with hypertension was hospitalized. None of the patients required ICU nor fatalities occurred in this group. Conclusions: This is the first report of surveillance of COVID-19 in Bolivia, with patients managed mainly with home isolation. Preparedness for a significant epidemic, as is going on in other countries, and the deployment of response plans for it, in the country is now taking place to mitigate the impact of the COVID-19 pandemic in the population.
KW - Bolivia
KW - Coronavirus disease 2019 (COVID-19)
KW - Epidemiology
KW - Latin America
KW - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
UR - http://www.scopus.com/inward/record.url?scp=85083018481&partnerID=8YFLogxK
U2 - 10.1016/j.tmaid.2020.101653
DO - 10.1016/j.tmaid.2020.101653
M3 - Artículo
C2 - 32247926
AN - SCOPUS:85083018481
SN - 1477-8939
VL - 35
JO - Travel Medicine and Infectious Disease
JF - Travel Medicine and Infectious Disease
M1 - 101653
ER -